Quantbot Technologies LP Fulcrum Therapeutics, Inc. Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$5.98 - $9.31 $83,893 - $130,609	14,029 New	14,029 $86,000
Q4 2022 Feb 13, 2023	BUY	$5.01 - $8.35 $781 - $1,302	156 Added 30.95%	660 $4,000
Q3 2022 Nov 07, 2022	BUY	$4.92 - $9.1 $2,479 - $4,586	504 New	504 $4,000
Q2 2022 Aug 09, 2022	SELL	$4.2 - $24.0 $19,320 - $110,400	-4,600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.96 - $23.65 $45,816 - $108,790	4,600 New	4,600 $108,000

149

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $227M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.